• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

autoimmune disease

baton
Pharma

Argenx telegraphs CEO switch as chief drug Vyvgart rolls ahead

Karen Massey, who joined the Amsterdam-based immunology specialist as chief operating officer in early 2023, is now set to assume the role of CEO.
Fraiser Kansteiner Jan 5, 2026 2:12pm
Amgen

Amgen nabs FDA nod for Uplizna in generalized myasthenia gravis

Dec 12, 2025 9:49am
Genentech

Roche's cancer med Gazyva scores FDA nod in lupus nephritis

Oct 20, 2025 10:15am
Outline of human head with female symbol inside
Favicon Fierce Biotech

Diabetes drug soothes brain inflammation in female mice with MS

Oct 15, 2025 6:16pm
Sanofi

Sanofi's Wayrilz snags FDA endorsement in ITP

Aug 29, 2025 5:59pm
On target clinical trial success bullseye score

RemeGen's telitacicept meets the mark in ph. 3 Sjögren's study

Aug 13, 2025 10:03am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings